FORMULATION AND EVALUATION OF DOMPERIDONE ORODISPERSIBLE TABLETS
2024, WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
https://doi.org/10.20959/WJPPS20243-26864Abstract
The most common and preferable route of drug administration is through the oral route. Novel oral drug delivery systems aim to enhance safety and efficacy of drug molecule by formulating a convenient dosage form for ease of administration and to achieve better patient compliance. Orodispersible tablets (ODTs) are among these systems, the concept of Orodispersible tablets is to disperse the tablets within seconds in the mouth in the presence of saliva with no need for water, and without any difficulty of swallowing due to the presence of superdisintegrants in their formulation. This study aims to solution the common problem of dysphagia by developing Orodispersible tablets that rapidly dissolve in the oral cavity without the need for water. The objective is to provide a convenient dosage form that improves patient compliance and enhances the safety and efficacy of therapy. Ten different formulations have been developed in this study physical and chemical tests, dissolution testing indicated good performance in certain formulations, the formulation was optimized to achieve desired characteristics such as optimum disintegration time, hardness, friability, and stability, The results showed successful formulations with good performance in dissolution testing and drug content analysis, The
References (53)
- Sastry SV, Nyshadham JR, Fix JA. Recent Technological Advances in Oral Drug Delivery -A Review. Pharm Sci Technol Today., 2000; 3(4): 138-145.
- Sravani M. Formulation and Evaluation of Mouth Dissolving Tablets of Nebivolol HCl for Treatment of Hypertension. Int J Pharma Chem Res., 2017; 3: 200-212.
- Gandhi L, Akhtar MS. Comparative Study on Effect of Natural and Synthetic Superdisintegrants in the Formulation of Orodispersible Tablets. J Drug Deliv Ther., 2019; 9(2): 507-513.
- Santosh Kumar R, Kumari A. Fast Dissolving Tablets: Waterless Patient Compliance Dosage Forms. J Drug Deliv Ther., 2019; 9(1): 303-317.
- LexiChem. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/9875401.
- Mueck W, Stampfuss J, Kubitza D, Becka M. Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban. Clin Pharmacokinet., 2014; 53: 1-16.
- Roy A. Orodispersible Tablets: A Review. Asian J Pharm Clin Res., 2016; 9(1): 19-26.
- Raymond CR, Paul JS, Marian EQ. Handbook of Pharmaceutical Excipients, 6th Edition. Pharmaceutical Press and American Pharmacists Association, 2009; S48-S760.
- Vishali T, Damodharan N. Orodispersible Tablets: A Review. Res J Pharm Tech., 2020; 13(5): 2522-2529.
- Nagar P, Singh K, Chauhan I, Verma M, Yasir M, Khan A, Sharma R, Gupta N. Orally disintegrating Tablets: Formulation, Preparation Techniques and Evaluation. J Appl Pharm Sci., 2011; 35-45.
- Sivagurunathan D. Formulation and In-Vitro Evaluation of Rivaroxaban Immediate Release Tablets: An Approach to Improving Oral Bioavailability Using Solid Dispersion Technique. The Tamil Nadu Dr. M.G.R. Medical University, 2020; 600032.
- Sandhyarani G, Sarangapani M. Formulation and Evaluation of Orodispersible Tablets of Domperidone. IOSR J Pharm., 2016; 6(9): 39-47.
- Upadhyay P, et al. A Review on Formulation and Evaluation Approaches for Fast Release Tablet. Mathews J Pharma Sci., 2023; 7(1): 15.
- Ramu S, Kumar YA, Rao DS, Ramakrishna G. Formulation and Evaluation of Valsartan Oral Dispersible Tablets by Direct Compression Method. Am J Adv Drug Deliv, 2014; 1: 2321-547X.
- Haseena A, kauser A, Fatima T, Majeed Z, Mohammed F. Formulation and Evaluation of Oral Disintegrating Tablets of Domperidone. WJPPS, 2018; 7(3): 615-640. DOI: 10.20959/wjpps20183-11043.
- Shahidulla SM, Khana K, Jayaveerab KN. Formulation and Evaluation of Fast Disintegrating Tablets of Domperidone. Anantapur (A.P) India, 2012; 10(3): 1521-1528.
- Zandi SK, Kumari R, Singh T. Formulation and Evaluation of Fast Disintegrating Tablets of Domperidone Using Chitosan-Glycine Conjugates as Superdisintegrant. Punjab, India, 2021; 45(1): 32-40. http://www.tjps.pharm.chula.ac.th.
- Parmar R B, Baria A H, Tank H M, Faldu S D. Formulation and Evaluation of Domperidone Fast Dissolving Tablets, Institute of Pharmaceutical Education and Research, 2009; 1(3): 483-487.
- Reddymasu SC, Soykan I, McCallum RW. Domperidone: Review of Pharmacology and Clinical Applications in Gastroenterology. ACG, 2007; 102(9): 2036-2045.
- Wilson DB, Dundee JW. Evaluation of the Anti-emetic Action of Domperidone. Anaesthesia, 1979; 34(8): 765-767.
- DRUGBANK. Domperidone: Uses, Interactions, Mechanism of Action, Drug Bank Online., Retrieved 4 July, 2023; from https://go.drugbank.com/drugs/DB01184.
- Laduron P, Leysen J. Domperidone, a Novel Gastrokinetic and Anti-nauseant Drug, Interacts Selectively with Dopamine Receptors. In Abstract of Paper presented at the 7th International Congress of Pharmacology, Paris, 1979.
- Champion, M C, Hartnett M, Yen M. Domperidone, a New Dopamine Antagonist. CMAJ: Canadian Medical Association Journal, 1986; 135(5): 457.
- Parkman HP, Jacobs MR, Mishra A, Hurdle JA, Sachdeva P, Gaughan JP, Krynetskiy E. Domperidone Treatment for Gastroparesis: Demographic and Pharmacogenetic Characterization of Clinical Efficacy and Side-Effects. Digestive Diseases and Sciences, 2011; 56(1): 115-124. doi:10.1007/s10620-010-1472-2. PMID 21063774.
- S2CID 39632855.
- Thomas B, Valappila P, Rouf A. Medication Used in Nausea and Vomiting of Pregnancy-a Review of Safety and Efficacy. Gynecol Obstet (Sunnyvale), 2015; 5(270): 2161-932.
- Nawale RB, Mohite KP. Formulation and Evaluation of Domperidone Orodispersible Tablet. Int J Pharm Sci Res., 2013; 4(9): 3670-3677. doi: 10.13040/IJPSR. 0975- 8232.4(9).3670-77.
- Alburyhi MM, Saif AA, Noman MA. Stability Study of Six Brands of Amoxicillin Trihydrate and Clavulanic Acid Oral Suspension Present in Yemen Markets. Journal of Chemical Pharm Research., 2013; 5(5): 293-296.
- Saif AA, Alburyhi MM, Noman MA. Evaluation of Vitamin and Mineral Tablets and Capsules in Yemen Market. Journal of Chemical Pharma Research, 2013; 5(9): 15-26.
- Alburyhi MM, Saif AA, Noman MA, Al-Ghorafi MA. Comparative Study of Certain Commercially Available Brands of Paracetamol Tablets in Sana'a City, Yemen. European Journal of Pharmaceutical and Medical Research, 2018; 5(12): 36-42.
- Alburyhi MM, Saif AA, Saif RM. Preformulation Study of Ceftriaxone and Ciprofloxacin for Lipid Based Drug Delivery Systems. EJUA-BA, 2022; 3(4): 339-350.
- Alburyhi MM, Saif AA, Noman MA, Yahya TA. Formulation, Development and Evaluation of Famotidine Orodispersible Tablets. European Journal of Pharmaceutical and Medical Research, 2023; 10(10): 56-62.
- Bary AA, El-Gazayerly ON, Alburyhi MM. Formulation of Immediate Release Lamotrigine Tablets and Bioequivalence Study. Journal of Chemical Pharm Research, 2013; 5(10): 266-271.
- Alburyhi MM, Saif AA, Noman MA, Saif RM. Recent Innovations of Delivery Systems for Antimicrobial Susceptibility Study of Ciprofloxacin Biodegradable Formulations for Post-Operative Infection Prophylaxis. European Journal of Pharmaceutical and Medical Research., 2023; 10(9): 32-36.
- Saif AA, Alburyhi MM, Noman MA, Almaktari AM. Formulation and Evaluation of Trimetazidine Hydrochloride and Clopidogrel Bisulphate Multi-unit Solid Dosage Forms. Journal of Chemical Pharm Research., 2014; 6(2): 421-426.
- Alburyhi MM, Saif AA, Noman MA, Saif RM. Recent Innovations of Delivery Systems for Antimicrobial Susceptibility Study of Ceftriaxone Biodegradable Formulations for Post-Operative Infection Prophylaxis. European Journal of Pharmaceutical and Medical Research., 2023; 10(8): 95-99.
- Aboghanem A, Alburyhi MM, Noman MA. Effect of Different Excipients on Formulation of Immediate Release Artemether/Lumefantrine Tablets. Journal of Chemical Pharm Research, 2013; 5(11): 617-625.
- Alburyhi MM, El-Shaibany A. Formulation and Evaluation of Anti-peptic Ulcer Capsules of Curcuma Longa Herbal Product. World Journal of Pharmaceutical Research, 2023; 12(22): 76-96.
- Alburyhi MM, Saif AA, Noman MA, Saeed SA, Al-Ghorafi MA. Formulation and Evaluation of Diclofenac Orodispersible Tablets. European Journal of Pharmaceutical and Medical Research, 2023; 10(9): 01-06.
- Saif AA, Alburyhi MM, Noman MA. Formulation and Evaluation of Ketoprofen Fast Dissolving Tablets. International Journal of Sciences, 2018; 7(09): 27-39.
- Alburyhi MM, El-Shaibany A. Formulation and Evaluation of Effervescent Granules of Artemisia Arborescence Herbal Product for Foodborne Illness. World Journal of Pharmacy and Pharmaceutical Sciences, 2023; 12(12): 1429-1444.
- Hamidaddin MA, Alburyhi MM, Noman MA, Saif AA. Formulation and Evaluation of Rosuvastatin Fast Dissolving Tablets. World Journal of Pharmacy and Pharmaceutical Sciences, 2023; 12(9): 2293-2303.
- Alburyhi MM, Saif AA, Noman MA, Salim YA, Hamidaddin MA. Formulation and Evaluation of Lisinopril Orally Disintegrating Tablets. World Journal of Pharmacy and Pharmaceutical Sciences, 2023; 12(9): 357-369.
- Alburyhi MM, El-Shaibany A. Formulation and Evaluation of Antitumor Activity of Artemisia Arborescence Extract Capsules as Dietary Supplement Herbal Product Against Breast Cancer. World Journal of Pharmaceutical Research, 2024; 13(3): 95-114.
- Noman MA, Alburyhi MM, El-Shaibany A, Alwesabi NA. Preformulation and Characterization Studies of Pandanus Odoratissimus L Extract Active Ingredient in Treatment of Nocturnal Enuresis. World Journal of Pharmacy and Pharmaceutical Sciences, 2024; 13(2): 1603-1620.
- Raweh SM, Noman MA, Alburyhi MM, Saif AA. Formulation and Evaluation of Anti- acne Gel of Azadirachta Indica Extract Herbal Product. European Journal of Pharmaceutical and Medical Research, 2024; 11(2): 427-433.
- Alburyhi MM, Saif AA, Noman MA, Yassin SH. Formulation and Evaluation of Simvastatin Orodispersible Tablets. World Journal of Pharmaceutical Research, 2023; 12(16): 1033-1047.
- Othman AM, Alburyhi MM, Al-Hadad GH. Formulation and Evaluation of Captopril Mouth Dissolving Tablets. European Journal of Pharmaceutical and Medical Research, 2024; 11(1): 18-28.
- Alburyhi MM, El-Shaibany A. Formulation and Evaluation of Oral Pharmaceutical Solution of Pandanus Odoratissimus L Extract Herbal Product in Treatment of Nocturnal Enuresis. World Journal of Pharmacy and Pharmaceutical Sciences, 2024; 13(1): 1840-1851.
- Alburyhi MM, Saif AA, Noman MA, Yahya TA, Al-Ghorafi MA. Formulation and Evaluation of Drotaverine Orally Disintegrating Tablets. World Journal of Pharmaceutical Research, 2023; 12(18): 66-79.
- Alburyhi MM, Saif AA, Noman MA, Al khawlani MA. Formulation and Evaluation of Bisoprolol Fast Dissolving. World Journal of Pharmaceutical Research, 2023; 12(16): 01-10.
- Alburyhi MM, Hamidaddin MA, Saif AA, Noman MA. Formulation and Evaluation of Rivaroxaban Orodispersible Tablets. World Journal of Pharmacy and Pharmaceutical Sciences., 2024; 13(2): 2066-2092.
- Alburyhi MM, El-Shaibany A. Formulation and Evaluation of Antibacterial Orodispersible Tablets of Artemisia Arborescence Extract Herbal Product. European Journal of Pharmaceutical and Medical Research., 2024; 11(2): 409-417.